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We assessed the clinical relevance and performed 
molecular characterization of 36 multidrug-resistant strains 
of Corynebacterium striatum. Pulsed-ﬁ   eld gel electropho-
resis conﬁ  rmed a single clone, possessing erm(X), tetA/B, 
cmxA/B, and aphA1 genes, but few related subclones. This 
strain is emerging as a pathogen in Italy.
I
solation of Corynebacterium spp. as the only organism 
from clinical specimens from patients, mostly with vary-
ing degrees of immunocompromisation and severe infec-
tions, is increasing in Italy. Therefore, we evaluated the 
microbiologic characteristics, resistance proﬁ  les, and simi-
larities among genomes of multidrug-resistant (MDR) C. 
striatum strains.
The Study
We evaluated 36 strains of MDR C. striatum, isolat-
ed from 3 hospitals in Italy during 2005–2007. Fourteen 
strains were from bronchoalveolar lavage (BAL) ﬂ  uid, 3 
from blood, 7 from central venous catheter tips, 5 from tra-
cheal aspirates, 4 from wound specimens, 1 from BAL and 
pleural ﬂ  uid, 1 from urine, and 1 from a lung biopsy speci-
men. To assess the clinical relevance of these strains, we 
used the Centers for Disease Control and Prevention 2004 
deﬁ  nition for nosocomial infections (www.cdc.gov/ncidod/
dhqp/nnis_pubs.html) (1) and tracked antimicrobial drug–
resistance determinants.
We identiﬁ  ed all strains as putative C. striatum by us-
ing the commercial system API 20 Coryne (bioMérieux, 
Marcy l’Etoile, France). C. striatum was differentiated 
from C. amycolatum by supplementary tests, i.e., tyrosine 
hydrolysis, N-acetylglucosamine assimilation, and phe-
nylacetic acid assimilation (2); it was reconﬁ  rmed by se-
quencing the internal fragment of the 16S rRNA gene (3). 
The American Type Culture Collection (ATCC) 6940 C. 
striatum strain was included as phenotypic and molecular 
control. All strains were stored at –80°C until use.
MICs were determined by using microdilution in 
cation-adjusted Mueller-Hinton broth in accordance with 
guidelines of the Clinical and Laboratory Standards Insti-
tute (CLSI) (4). The following antimicrobial drugs were 
tested: tigecycline and piperacillin/tazobactam, oxacillin, 
gentamicin, kanamycin, levoﬂ  oxacin, erythromycin, clin-
damycin, piperacillin, vancomycin, teicoplanin, tetracy-
cline, moxiﬂ  oxacin, imipenem, meropenem, quinupristin/
dalfopristin, linezolid, and daptomycin. Etest strips (AB-
BIODISK, Solna, Sweden) were used for vancomycin, 
teicoplanin, linezolid, and daptomycin. Daptomycin Etests 
were performed by using Muller-Hinton agar (Oxoid, Mi-
lan, Italy), supplemented to a ﬁ  nal concentration of 50 
mg/L calcium.
In the absence of approved breakpoints for Coryne-
bacterium spp., we used those for α-hemolytic streptococci 
of the viridans group. Results were read after incubation 
at 37°C for 18–24 h. Susceptibility to daptomycin was 
deﬁ  ned as MIC <1 mg/L (5); CLSI guideline MIC break-
points were used for all other drugs tested (4).
To further characterize the C. striatum isolates, we used 
2 DNA ﬁ   ngerprinting techniques: automated ribotyping 
(RiboPrinter Microbial Characterization System; DuPont 
Qualicon, Wilmington, DE, USA) with EcoRI as restric-
tion enzyme and pulsed-ﬁ  eld gel electrophoresis (PFGE) 
macrorestriction analysis with 2 enzymes (XbaI and SwaI; 
New England Biolabs, Beverly, MA, USA). We had used 
4 enzymes (XbaI, SwaI, Sﬁ  I, and PacI) to test 10 random 
strains, but because XbaI and SwaI enzyme-restriction pat-
terns gave a better resolution for low and high molecular 
weight fragments, respectively, we used only these 2 re-
striction enzymes to type all 36 strains.
Whole genomic DNA chromosomal extraction, mac-
rorestriction digestion, and PFGE (CHEF-DR II apparatus; 
Bio-Rad, Hercules, CA, USA) were performed as previous-
ly reported (6). Macrorestriction fragments were separated 
on 1% (wt/vol) ultrapure agarose gels (Sigma Aldrich, St. 
Louis, MO, USA) at 6 V/cm, for 21 h at 14°C with pulse 
times of 0.1–5 s, to separate XbaI fragments, and for 23 
h with pulse times of 1–70 s, to separate SwaI fragments. 
Lambda DNA concatemers (New England BioLabs) were 
used as molecular size markers. Similarities among mac-
rorestriction patterns were identiﬁ  ed according to estab-
lished criteria (7).
The sequence of pTP10 (GenBank accession no. 
AF024666) (8) was used to design the primers for erm(X), 
tetA and tetB, cmx, aphA1, and repB genes. The VectorN-
TI program (Invitrogen, www.invitrogen.com) was used 
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ﬁ   rst by ampliﬁ   cation and sequencing of the resistance 
determinants and the replication gene (repB) and then by 
XbaI and SwaI PFGE hybridizations, performed with the 
speciﬁ  c probes (erm(X), tetAB, cmx, and aphA1), follow-
ing a protocol previously described (9). The PCR ampliﬁ  -
cations were performed in a Techne TC412 thermal cycler 
(Barloworld Scientiﬁ  c, Staffordshire, UK). All primers and 
the related probe regions used in hybridization experiments 
are shown in Table 1.
All C. striatum isolates were recovered from hospital-
ized patients who had undergone surgery or been admitted 
to intensive care units (Table 2). We documented 19 cases 
of infections and discarded 17 as contaminants. The isolates 
that were considered causes of infections were responsible 
for 8 cases of ventilator-associated pneumonia (including 1 
with associated pleural empyema), 2 cases of pneumonia, 1 
case of catheter-related sepsis, 2 cases of ventilator-associ-
ated tracheobronchitis, and 6 cases of wound infections.
The 36 strains showed an MDR phenotype, including 
resistance to >3 classes of drugs; MICs required to inhibit 
growth of 90% (MIC90) were penicillins >256 mg/L, car-
bapenems >256 mg/L, gentamicin 32 mg/L, levoﬂ  oxacin 
256 mg/L, tetracycline >256 mg/L, lincosamides >256 
mg/L, and erythromycin 32 mg/L. C. striatum strains were 
susceptible to only the most recent drugs used for treatment 
of infections with gram-positive organisms, such as glyco-
peptides and tigecycline (MIC90 1 mg/L), quinupristin/dal-
fopristin and daptomycin (MIC90 0.25 mg/L), and linezolid 
(MIC90 2 mg/L).  A discrepancy was found when suscepti-
bility testing using a disk-diffusion method was performed 
on different strains; the inhibition zone of erythromycin 
was always in the intermediate range, even if MICs for this 
drug were in the low-resistance range.  
 Ribotyping gave a unique proﬁ  le for all strains in 
this study. PFGE enabled us to discriminate the right 
number of macrorestriction fragments (5,10,11) for pat-
tern comparison.
Analyses of SwaI digestion patterns showed that of the 
36 strains, only 1 clone had 3 different subtypes (30 strains 
subtype a1, 4 strains a2, and 2 strains a3). Macrorestriction 
analysis with XbaI showed almost comparable results (27 
strains A1, 7 strains A2, and 2 strains A3) (Figure). This 
genotyping method and the enzymes used were deﬁ  ned as 
appropriate, comparing PFGE patterns of our clinical iso-
lates with C. striatum ATCC 6940 type strain, which was 
different with respect to the epidemic strains. This result 
demonstrates that single MDR C. striatum clones had been 
selected and were circulating in the 3 hospitals.
Further, the molecular characterization of some of 
the resistance genes in the 36 C. striatum isolates demon-
strated the presence of erm(X), codifying for the resistance 
to erythromycin and clindamycin; tetA, and tetB, codify-
ing for the resistance to tetracycline, oxytetracycline, and 
oxacillin; and cmx and aphA1, responsible for resistance 
to aminoglycosides and chloramphenicol, respectively. 
The presence of pTP10 carrying all these determinants was 
conﬁ  rmed by ampliﬁ  cation and sequencing of these genes 
and the replication gene of the plasmid, together with hy-
bridization experiments demonstrating that all resistance 
determinants were localized in the same hybridization 
band generated by each probe onto PFGEXbaI (≈15 kb) and 
PFGESwaI (≈280 kb) membranes (Figure).
Conclusions
We report isolation of MDR C. striatum from clini-
cal specimens responsible for cases of pneumonia, cath-
eter-related bacteremia, and wound infections. Infections 
sustained from this species are strongly associated with 
devices, not only tubes or catheters (91%) but also sternal 
surgical wound wires.
The MDR phenotype of these strains was immediately 
observed and was responsible for the alarm that led to the 
subsequent in-depth examination of these strains. Their 
clonal nature, as demonstrated in our study, is of particu-
lar concern. Further, the MDR phenotype correlated to the 
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Table 1. Primer conditions, PCR products, and related sequences confirmed by BLAST analysis of 36 strains of multidrug-resistant 
Corynebacterium  striatum, Italy, 2005–2007* 
Primer Related resistance  Sequence (5ƍ o 3ƍ)
Temperature, 
°C Size, bp
BLAST from–to, 
bp
ermX up 
ermX down
Erythromycin and 
clindamycin
AACCATGATTGTGTTTCTGAACG 
ACCAGGAAGCGGTGCCCT
57 566 2,285–2,850
tetA up 
tetB down
Tetracycline, oxytetracycline, 
and oxacillin
TTAGCGTTCGGCGACCTGG 
AACTGGGTGCCTTCAGGGTC
58 1,829 5,496–7,324
cmxB up 
cmxA down
Cloramphenicol (2 identical 
subunits)
AGTCGGTATGGTCGTCGGC 
GCTCCGATATTCAATGCTGCG
57 879 16,031–16,909 
36,078–36,956
aphA1 up 
aphA1 down
Aminoglycoside GGCAAGATCCTGGTATCGGTCT 
AGACTAAACTGGCTGACGGCAT
57 480 41,859–42,338
repB up 
repB down
Replicase CGATCTGGAATTTGTCTGCCGT 
CTGGTTGATAGACCCCGTGT
57 875 32,523–33,397
*BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) analysis of each gene with pTP10 sequence (GenBank accession no. AF024666) showed nucleotide 
identities >99%. Clonal Multidrug-Resistant C. striatum strains
presence of the pTP10 plasmid, which demonstrates that 
these MDR microorganisms acquired not only the capabil-
ity to cause infections but also increased resistance and the 
ability to spread by virtue of their clonal nature. The only 
drugs still active against these MDR strains are glycopep-
tides, linezolid, quinopristin/dalfopristin, daptomycin, and 
tigecycline. To avoid using drugs that appear active in vitro 
but that could be ineffective in vivo, clinicians should be 
aware of the circulation of these MDR strains. 
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